nach oben

Erschienen in:

18.09.2021 | Original Article

Photobiomodulation therapy preconditioning modifies nitric oxide pathway and oxidative stress in human-induced pluripotent stem cell-derived ventricular cardiomyocytes treated with doxorubicin

verfasst von: Allan Luís Barboza Atum, José Almir Alves da Silva, Danila Marques, Renato Araújo Prates, Fernanda Marciano Consolim-Colombo, Maria Cláudia Costa Irigoyen, Maria Aparecida Dalboni, Maria Cristina Chavantes, José Antônio Silva Jr.

Erschienen in: Lasers in Medical Science | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Doxorubicin (DOX) is an anthracycline antibiotic that exhibits high heart toxicity. Human-induced pluripotent stem cell-derived ventricular cardiomyocytes (hiPSC-vCMs) are important in vitro models for testing drug cardiotoxicity. Photobiomodulation therapy (PBMT) is a non-invasive therapy that stimulates cells growth and self-repair using light irradiation. This study aimed to investigate the in vitro effects of PBMT preconditioning on cardiotoxicity induced by DOX. HiPSC-vCMs were treated with PBMT for 500 s, followed by the addition of 2 μM DOX. LED irradiation preconditioning parameters were at 660 nm with an irradiance of 10 mW/cm², performing 5 J/cm², followed by 24-h DOX exposure (2 μM). Human iPSC-vCMs treated with 2 μM DOX or irradiated with PBMT composed the second and third groups, respectively. The control group did neither receive PBMT preconditioning nor DOX and was irradiated with a white standard lamp. Cells from all groups were collected to perform mRNA and miRNA expressions quantification. PBMT, when applied before the DOX challenge, restored the viability of hiPSC-vCMs and reduced ROS levels. Although downregulated by DOX, myocardial UCP2 mRNA expression presented marked upregulation after PBMT preconditioning. Expression of eNOS and UCP2 mRNA and NO production were decreased after DOX exposure, and PBMT preconditioning before the DOX challenge reversed these changes. Moreover, our data indicated that PBMT preconditioning lowered the miR-24 expression. Our data suggested that PBMT preconditioning ameliorated in vitro DOX-induced cardiotoxicity on transcription level, restoring NO levels and reducing oxidative stress.

Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS et al (2009) Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 16(25):3267–3285. https://doi.org/10.2174/092986709788803312CrossRefPubMed

Songbo M, Lang H, Xinyong C, Bin X, Ping Z, Liang S (2019) Oxidative stress injury in doxorubicin-induced cardiotoxicity. Toxicol Lett 307:41–48. https://doi.org/10.1016/j.toxlet.2019.02.013CrossRefPubMed

Li DL, Hill JA (2014) Cardiomyocyte autophagy and cancer chemotherapy. J Mol Cell Cardiol 71:54–61. https://doi.org/10.1016/j.yjmcc.2013.11.007CrossRefPubMed

Chen RC, Xu XD, Zhi Liu X, Sun GB, Zhu YD, Dong X et al (2015) Total Flavonoids from Clinopodium chinense (Benth.) O. Ktze protect against doxorubicin-induced cardiotoxicity in vitro and in vivo. Evid Based Complement Alternat Med 2015:472565. https://doi.org/10.1155/2015/472565CrossRefPubMedPubMedCentral

Lipshultz SE, Alvarez JA, Scully RE (2008) Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart 94(4):525–533. https://doi.org/10.1136/hrt.2007.136093CrossRefPubMed

Oliveira PJ, Bjork JA, Santos MS, Leino RL, Froberg MK, Moreno AJ et al (2004) Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity. Toxicol Appl Pharmacol 200(2):159–168. https://doi.org/10.1016/j.taap.2004.04.005CrossRefPubMed

Rochette L, Guenancia C, Gudjoncik A, Hachet O, Zeller M, Cottin Y et al (2015) Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms. Trends Pharmacol Sci 36(6):326–348. https://doi.org/10.1016/j.tips.2015.03.005CrossRefPubMed

Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676. https://doi.org/10.1016/j.cell.2006.07.024CrossRefPubMed

Da Rocha AM, Campbell K, Mironov S, Jiang J, Mundada L, Guerrero-Serna G et al (2017) hiPSC-CM monolayer maturation state determines drug responsiveness in high throughput pro-arrhythmia screen. Sci Rep 7(1):13834. https://doi.org/10.1038/s41598-017-13590-yCrossRefPubMedPubMedCentral

10.

Eder A, Vollert I, Hansen A, Eschenhagen T (2016) Human engineered heart tissue as a model system for drug testing. Adv Drug Deliv Rev 96:214–224. https://doi.org/10.1016/j.addr.2015.05.010CrossRefPubMed

11.

De Rosa S, Curcio A, Indolfi C (2014) Emerging role of microRNAs in cardiovascular diseases. Circ J 78(3):567–575. https://doi.org/10.1253/circj.cj-14-0086CrossRefPubMed

12.

Santana ET, Feliciano RS, Serra AJ, Brigidio E, Antonio EL, Tucci PJF et al (2016) Comparative mRNA and MicroRNA profiling during acute myocardial infarction induced by coronary occlusion and ablation radio-frequency currents. Front Physiol 7:1–14. https://doi.org/10.3389/fphys.2016.00565CrossRef

13.

De Melo BL, Vieira SS, Antônio EL, dos Santos LFN, Portes LA, Feliciano RS et al (2016) Exercise training attenuates right ventricular remodeling in rats with pulmonary arterial stenosis. Front Physiol 7:541. https://doi.org/10.3389/fphys.2016.00541CrossRefPubMedPubMedCentral

14.

Zhao L, Tao X, Qi Y, Xu L, Yin L, Peng J (2018) Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress. Redox Biol 16:189–198. https://doi.org/10.1016/j.redox.2018.02.026CrossRefPubMedPubMedCentral

15.

Lai L, Chen J, Wang N, Zhu G, Duan X, Ling F (2017) MiRNA-30e mediated cardioprotection of ACE2 in rats with doxorubicin-induced heart failure through inhibiting cardiomyocytes autophagy. Life Sci 169:69–75. https://doi.org/10.1016/j.lfs.2016.09.006CrossRefPubMed

16.

Gupta SK, Garg A, Avramopoulos P, Engelhardt S, Streckfuss-Bömeke K, Batkai S et al (2019) miR-212/132 Cluster modulation prevents doxorubicin-Mediated Atrophy and Cardiotoxicity. Mol Ther 27(1):17–28. https://doi.org/10.1016/j.ymthe.2018.11.004CrossRefPubMed

17.

Bortone F, Santos HA, Albertini R, Pesquero JB, Costa MS, Silva JA Jr (2008) Low level laser therapy modulates kinin receptors mRNA expression in the subplantar muscle of rat paw subjected to carrageenan-induced inflammation. Int Immunopharmacol 8(2):206–210. https://doi.org/10.1016/j.intimp.2007.09.004CrossRefPubMed

18.

Hamblin MR (2017) Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys 4(3):337–361. https://doi.org/10.3934/biophy.2017.3.337CrossRefPubMedPubMedCentral

19.

Manchini MT, Serra AJ, Feliciano RS, Santana ET, Antônio EL, de Carvalho PTC et al (2014) Amelioration of cardiac function and activation of anti-inflammatory vasoactive peptides expression in the rat myocardium by low level laser therapy. PLoS ONE 9(7):e101270. https://doi.org/10.1371/journal.pone.0101270CrossRefPubMedPubMedCentral

20.

Agrawal T, Gupta GK, Rai V, Carroll JD, Hamblin MR (2014) Preconditioning with low-level laser (light) therapy: light before the storm. Dose Response 12(4):619–649. https://doi.org/10.2203/dose-response.14-032.AgrawalCrossRefPubMedPubMedCentral

21.

Liu Y, Zhang H (2016) Low-level laser irradiation precondition for cardiac regenerative therapy. Photomed Laser Surg 34(11):572–579. https://doi.org/10.1089/pho.2015.4058CrossRefPubMed

22.

Tuby H, Maltz L, Oron U (2006) Modulations of VEGF and iNOS in the rat heart by low level laser therapy are associated with cardioprotection and enhanced angiogenesis. Lasers Surg Med 38(7):682–688CrossRef

23.

Zhang H, Hou JF, Shen Y, Wang W, Wei YJ, Hu S (2010) Low level laser irradiation precondition to create friendly milieu of infarcted myocardium and enhance early survival of transplanted bone marrow cells. J Cell Mol Med 14(7):1975–1987. https://doi.org/10.1111/j.1582-4934.2009.00886.xCrossRefPubMedPubMedCentral

24.

Zhu R, Blazeski A, Poon E, Costa KD, Tung L, Boheler KR (2014) Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther 5:117. https://doi.org/10.1186/scrt507CrossRefPubMedPubMedCentral

25.

Mathur A, Loskill P, Shao K, Huebsch N, Hong S, Marcus SG et al (2015) Human iPSC-based cardiac microphysiological system for drug screening applications. Sci Rep 5:8883. https://doi.org/10.1038/srep08883CrossRefPubMedPubMedCentral

26.

David R, Franz WM (2012) From pluripotency to distinct cardiomyocyte subtypes. Physiology 27:119–129. https://doi.org/10.1152/physiol.00044.2011CrossRefPubMed

27.

Xia N, Bollinger L, Steinkamp-Fenske K, Förstermann U, Li H (2010) Prunella vulgaris L Upregulates eNOS expression in human endothelial cells. Am J Chin Med 38(3):599–611. https://doi.org/10.1142/S0192415X10008081CrossRefPubMed

28.

Ankri R, Friedman H, Savion N, Kotev-Emeth S, Breitbart H, Lubart R (2010) Visible light induces nitric oxide (NO) formation in sperm and endothelial cells. Lasers Surg Med 42(4):348–352. https://doi.org/10.1002/lsm.20849CrossRefPubMed

29.

Rizzi M, Migliario M, Tonello S, Rocchetti V, Renò F (2018) Photobiomodulation induces in vitro re-epithelialization via nitric oxide production. Lasers Med Sci 33(5):1003–1008. https://doi.org/10.1007/s10103-018-2443-7CrossRefPubMed

30.

Huang SJ, Lee SY, Teng YH, Lee SD, Cheng YJ (2021) Photobiomodulation therapy to promote angiogenesis in diabetic mice with hindlimb ischemia. Photobiomodul Photomed Laser Surg 39(7):453–462. https://doi.org/10.1089/photob.2020.4896CrossRefPubMed

31.

Zhang R, Mio Y, Pratt PF, Lohr N, Warltier DC, Whelan HT et al (2009) Near infrared light protects cardiomyocytes from hypoxia and reoxygenation injury by a nitric oxide dependent mechanism. J Mol Cell Cardiol 46(1):4–14. https://doi.org/10.1016/j.yjmcc.2008.09.707CrossRefPubMed

32.

Oishi JC, De Moraes TF, Buzinari TC, Cárnio EC, Parizotto NA, Rodrigues GJ (2017) Hypotensive acute effect of photobiomodulation therapy on hypertensive rats. Life Sci 178:56–60. https://doi.org/10.1016/j.lfs.2017.04.011CrossRefPubMed

33.

Buzinari TC, de Moraes TF, Cárnio EC, Lopes LA, Salgado HC, Rodrigues GJ (2020) Photobiomodulation induces hypotensive effect in spontaneously hypertensive rats. Lasers Med Sci 35(3):567–572. https://doi.org/10.1007/s10103-019-02849-7CrossRefPubMed

34.

Totzeck M, Hendgen-Cotta UB, Rassaf T (2017) Nitrite-nitric oxide signaling and cardioprotection. Adv Exp Med Biol 982:335–346. https://doi.org/10.1007/978-3-319-55330-6_18CrossRefPubMed

35.

Rassaf T, Preik M, Kleinbongard P, Lauer T, Hei C, Strauer BE et al (2002) Evidence for in vivo transport of bioactive nitric oxide in human plasma. J Clin Invest 109(9):1241–1248. https://doi.org/10.1172/JCI14995CrossRefPubMedPubMedCentral

36.

Mu H, Liu H, Zhang J, Huang J, Zhu C, Lu Y, Shi Y, Wang Y (2019) Ursolic acid prevents doxorubicin-induced cardiac toxicity in mice through eNOS activation and inhibition of eNOS uncoupling. J Cell Mol Med 23(3):2174–2183. https://doi.org/10.1111/jcmm.14130CrossRefPubMedPubMedCentral

37.

Dutra MRH, Feliciano RS, Jacinto KR, Gouveia TLF, Brigidio E, Serra AJ et al (2018) Protective role of UCP2 in oxidative stress and apoptosis during the silent phase of an experimental model of epilepsy induced by pilocarpine. Oxi Med Cell Logev 2018:6736721. https://doi.org/10.1155/2018/6736721CrossRef

38.

Nègre-Salvayre A, Hirtz C, Carrera G, Cazenave R, Troly M, Salvayre R et al (1997) A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J 11(10):809–815CrossRef

39.

Kizaki T, Suzuki K, Hitomi Y, Taniguchi N, Saitoh D, Watanabe K, Onoé K, Day NK, Good RA, Ohno H (2002) Uncoupling protein 2 plays an important role in nitric oxide production of lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci USA 99(14):9392–7. https://doi.org/10.1073/pnas.142206299CrossRefPubMedPubMedCentral

40.

Lee KU, Lee IK, Han J, Song DK, Kim YM, Song HS, Kim HS, Lee WJ, Koh EH, Song KH, Han SM, Kim MS, Park IS, Park JY (2005) Effects of recombinant adenovirus-mediated uncoupling protein 2 overexpression on endothelial function and apoptosis. Circ Res 96(11):1200–1207. https://doi.org/10.1161/01.RES.0000170075.73039.5bCrossRefPubMed

41.

Fallahi AA, Shekarfroush S, Rahimi M, Jalali A, Khoshbaten A (2016) Alteration in cardiac uncoupling proteins and eNOS gene expression following high-intensity interval training in favor of increasing mechanical efficiency. Iran J Basic Med Sci 19(3):258–264PubMedPubMedCentral

42.

Hong J, Park E, Lee J, Lee Y, Rooney BV, Park Y (2021) Exercise training mitigates ER stress and UCP2 deficiency-associated coronary vascular dysfunction in atherosclerosis. Sci Rep 11(1):15449. https://doi.org/10.1038/s41598-021-94944-5CrossRefPubMedPubMedCentral

43.

Wang Y, Lei T, Yuan J, Wu Y, Shen X, Gao J et al (2018) GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress. Redox Biol 17:25–34. https://doi.org/10.1016/j.redox.2018.04.009CrossRefPubMedPubMedCentral

44.

Hu C, Zhang X, Wei W, Zhang N, Wu H, Ma Z, Li L, Deng W, Tang Q (2019) Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKα/UCP2 pathway. Acta Pharm Sin B 9(4):690–701. https://doi.org/10.1016/j.apsb.2019.03.003CrossRefPubMedPubMedCentral

45.

Li Q, Li C, Xi S, Li X, Ding L, Li M (2019) The effects of photobiomodulation therapy on mouse pre-osteoblast cell line MC3T3-E1 proliferation and apoptosis via miR-503/Wnt3a pathway. Lasers Med Sci 34(3):607–614. https://doi.org/10.1007/s10103-018-2636-0CrossRefPubMed

46.

Feliciano RS, Atum ALB, Ruiz EGS, Serra AJ, Antonio EL, Manchini MT, Silva JMAS, Tucci PJF, Nathanson L, Morris M, Chavantes MC, Silva JA Jr (2021) Photobiomodulation therapy on myocardial infarction in rats: transcriptional implications to cardiac remodeling. Lasers Surg Med. https://doi.org/10.1002/lsm.23407CrossRefPubMed

47.

Fiedler J, Jazbutyte V, Kirchmaier BC, Gupta SK, Lorenzen J, Hartmann D et al (2011) MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 124(6):720–730. https://doi.org/10.1161/CIRCULATIONAHA.111.039008CrossRefPubMed

48.

Qian L, Van Laake LW, Huang Y, Liu S, Wendland MF, Srivastava D (2011) miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med 208(3):549–560. https://doi.org/10.1084/jem.20101547CrossRefPubMedPubMedCentral

49.

Guo C, Deng Y, Liu J, Qian L (2015) Cardiomyocyte-specific role of miR-24 in promoting cell survival. J Cell Mol Med 19(1):103–112. https://doi.org/10.1111/jcmm.12393CrossRefPubMed

50.

Meloni M, Marchetti M, Garner K, Littlejohns B, Sala-Newby G, Xenophontos N et al (2013) Local inhibition of microRNA-24 improves reparative angiogenesis and left ventricle remodeling and function in mice with myocardial infarction. Mol Ther 21(7):1390–1402. https://doi.org/10.1038/mt.2013.89CrossRefPubMedPubMedCentral

51.

Yang J, Xu J, Danniel M, Wang X, Wang W, Zeng L, Shen L (2018) The interaction between XBP1 and eNOS contributes to endothelial cell migration. Exp Cell Res 363(2):262–270. https://doi.org/10.1016/j.yexcr.2018.01.016CrossRefPubMed

52.

Wang M, Sun L, Ding W, Cai S, Zhao Q (2019) Ablation alleviates atrial fibrillation by regulating endothelial nitric oxide signaling pathways synthase/nitric oxide via miR-155-5p and miR-24-3p. J Cell Biochem 120(3):4451–4462. https://doi.org/10.1002/jcb.27733CrossRefPubMed

53.

Li HM, Mo ZW, Peng YM, Li Y, Dai WP, Yuan HY, Chang FJ, Wang TT, Wang M, Hu KH, Li XD, Ning DS, Chen YT, Song YK, Lu XL, Pei Z, Dong YG, Wang ZP, Zhang X, Xu YQ, Wang SM, Ou ZJ, Ou JS (2020) Angiogenic and antiangiogenic mechanisms of high-density lipoprotein from healthy subjects and coronary artery diseases patients. Redox Biol 36:101642. https://doi.org/10.1016/j.redox.2020.101642CrossRefPubMedPubMedCentral

54.

Marchetti M, Meloni M, Anwar M, Zen AAH, Sala-Newby G, Slater S, Ford K, Caporali A, Emanueli C (2020) MicroRNA-24-3p Targets notch, and other vascular morphogens to regulate post-ischemic microvascular responses in limb muscles. Int J Mol Sci 21(5):1733. https://doi.org/10.3390/ijms21051733CrossRefPubMedCentral

55.

Wang J, Huang W, Xu R, Nie Y, Cao X, Meng J et al (2012) MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J Cell Mol Med 16(9):2150–2160. https://doi.org/10.1111/j.1582-4934.2012.01523.xCrossRefPubMedPubMedCentral

Titel: Photobiomodulation therapy preconditioning modifies nitric oxide pathway and oxidative stress in human-induced pluripotent stem cell-derived ventricular cardiomyocytes treated with doxorubicin
verfasst von: Allan Luís Barboza Atum
José Almir Alves da Silva
Danila Marques
Renato Araújo Prates
Fernanda Marciano Consolim-Colombo
Maria Cláudia Costa Irigoyen
Maria Aparecida Dalboni
Maria Cristina Chavantes
José Antônio Silva Jr.
Publikationsdatum: 18.09.2021
Verlag: Springer London
Erschienen in: Lasers in Medical Science / Ausgabe 3/2022
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-021-03416-9

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Photobiomodulation therapy preconditioning modifies nitric oxide pathway and oxidative stress in human-induced pluripotent stem cell-derived ventricular cardiomyocytes treated with doxorubicin

Abstract

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2022

Effect of transcranial near-infrared photobiomodulation on cognitive outcomes in D-galactose/AlCl3 induced brain aging in BALB/c mice

Diode laser–assisted inferior turbinoplasty in resistant cases of allergic rhinitis: a clinical and histopathological study

Effects of low-level laser therapy on reducing pain, edema, and trismus after orthognathic surgery: a systematic review

Laterally closed tunnel technique with and without adjunctive photobiomodulation therapy for the management of isolated gingival recession—a randomized controlled assessor-blinded clinical trial

Correction to: Q‑S laser micro‑drilling and multipass full‑beam Q‑S laser for tattoo removal — a case series

Efficiency and safety of laser-assisted hatching on vitrified-warmed blastocyst transfer cycles: a prospective control trial